Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
Bladder cancer is a heterogeneous disease in molecular, histological and clinical aspects. Treatment should also be considered from different angles - surgery, intravesical chemo- or immunotherapy, radiation therapy and lifestyle changes. Intravesical treatment of superficial bladder cancer with Еpi...
Saved in:
| Main Authors: | Boyan Atanasov, Nikolay Nikolov, Vladislav Dunev, Angel Anatoliev, Nikolay Kolev, Martin Stoykov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2022-06-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34623/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01) -
Cluster analysis of hotspots and research trends of epirubicin-induced cardiotoxicity: a bibliometric study
by: Dongning He, et al.
Published: (2025-08-01) -
Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
by: Douglas O. Ochora, et al.
Published: (2025-06-01) -
Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
by: Tian‐Huei Chu, et al.
Published: (2018-06-01) -
Multi-Centre Study of Progression Factors and Intravesical Recurrence in Patients with Urothelial Carcinoma of the Upper Urinary Tract
by: Lucía García-Morales, et al.
Published: (2024-11-01)